Incidence of thrombocytopenia with gemcitabine-based therapy and influence of dosing and schedule

Anticancer Drugs. 2001 Apr;12(4):383-5. doi: 10.1097/00001813-200104000-00012.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Comorbidity
  • Deoxycytidine / administration & dosage*
  • Deoxycytidine / adverse effects*
  • Deoxycytidine / analogs & derivatives
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Gemcitabine
  • Hemorrhage / chemically induced
  • Hemorrhage / epidemiology
  • Hemorrhage / therapy
  • Humans
  • Incidence
  • Platelet Transfusion
  • Retrospective Studies
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / epidemiology*

Substances

  • Deoxycytidine
  • Cisplatin
  • Gemcitabine